Header Logo

Giselle Mosnaim

Concepts (261)

Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.


Name Number of Publications Most Recent Publication Publications by All Authors Concept Score Why?
Asthma
52
2023
156
14.750
Why?
Anti-Asthmatic Agents
17
2023
31
5.070
Why?
Hypersensitivity
7
2023
47
2.670
Why?
Adrenal Cortex Hormones
13
2023
115
2.590
Why?
Physicians
6
2022
122
2.570
Why?
Telemedicine
7
2023
97
2.500
Why?
Medication Adherence
12
2023
49
2.360
Why?
Patient Education as Topic
9
2021
131
2.310
Why?
Burnout, Professional
4
2022
29
2.260
Why?
Coronavirus Infections
7
2020
86
1.960
Why?
Pneumonia, Viral
7
2020
90
1.950
Why?
Child
29
2023
1295
1.590
Why?
Humans
79
2023
27072
1.530
Why?
Community Health Workers
7
2022
35
1.380
Why?
Administration, Inhalation
14
2022
37
1.310
Why?
Adolescent
24
2023
2172
1.180
Why?
Pandemics
11
2022
236
1.090
Why?
Behavior Therapy
2
2017
86
0.990
Why?
Caregivers
7
2019
197
0.940
Why?
Nebulizers and Vaporizers
8
2022
21
0.900
Why?
Mobile Applications
2
2020
29
0.810
Why?
Betacoronavirus
5
2020
74
0.790
Why?
Emergency Service, Hospital
8
2020
255
0.770
Why?
Biological Products
1
2022
43
0.740
Why?
Environmental Exposure
2
2018
17
0.690
Why?
Allergy and Immunology
4
2020
5
0.690
Why?
Monitoring, Ambulatory
1
2020
19
0.690
Why?
Poverty
3
2020
96
0.670
Why?
Surveys and Questionnaires
8
2022
1144
0.650
Why?
Adult
20
2023
7831
0.640
Why?
Parents
2
2018
113
0.610
Why?
Emigrants and Immigrants
2
2018
21
0.600
Why?
Respiratory Tract Diseases
1
2018
8
0.590
Why?
Physician-Patient Relations
1
2018
44
0.590
Why?
Female
31
2023
15212
0.590
Why?
Health Literacy
4
2021
108
0.580
Why?
Registries
1
2019
189
0.580
Why?
Male
30
2023
14772
0.570
Why?
Self Care
5
2020
89
0.560
Why?
Decision Making
1
2018
223
0.520
Why?
Child, Preschool
8
2022
641
0.510
Why?
Assertiveness
1
2015
7
0.500
Why?
Urban Population
5
2013
153
0.470
Why?
Chicago
7
2019
949
0.450
Why?
United States
9
2023
2035
0.440
Why?
Social Support
2
2021
196
0.430
Why?
Family
3
2021
103
0.420
Why?
Bronchodilator Agents
3
2022
13
0.420
Why?
Patient Compliance
2
2011
150
0.410
Why?
Immunization, Passive
5
2023
11
0.400
Why?
MP3-Player
2
2013
5
0.400
Why?
Minority Groups
4
2019
80
0.400
Why?
House Calls
3
2021
15
0.380
Why?
Electronics
2
2021
9
0.370
Why?
Fellowships and Scholarships
2
2022
36
0.360
Why?
Health Services Accessibility
2
2023
112
0.360
Why?
Computer Security
2
2020
6
0.350
Why?
Insurance, Health, Reimbursement
2
2020
15
0.350
Why?
Health Knowledge, Attitudes, Practice
2
2011
164
0.340
Why?
Socioeconomic Factors
5
2021
302
0.340
Why?
Stress Disorders, Post-Traumatic
4
2021
231
0.330
Why?
Hospitalization
3
2022
300
0.320
Why?
Asthma, Exercise-Induced
1
2009
1
0.310
Why?
Adrenergic beta-Agonists
1
2009
16
0.310
Why?
Athletes
1
2009
88
0.290
Why?
Communication Barriers
1
2007
4
0.290
Why?
Adaptation, Psychological
2
2020
175
0.290
Why?
Quality Improvement
3
2018
138
0.280
Why?
Language
1
2007
63
0.280
Why?
Research Design
2
2019
185
0.270
Why?
Severity of Illness Index
5
2021
879
0.240
Why?
Electronic Health Records
3
2020
73
0.240
Why?
Monitoring, Physiologic
2
2022
68
0.220
Why?
Albuterol
4
2022
15
0.220
Why?
Urticaria
1
2023
4
0.220
Why?
Transfusion Reaction
1
2023
6
0.220
Why?
One Health
1
2023
1
0.210
Why?
Middle Aged
8
2022
8923
0.210
Why?
Patient Preference
1
2023
35
0.210
Why?
Social Determinants of Health
1
2023
32
0.210
Why?
Glucocorticoids
2
2020
68
0.200
Why?
Health Status Disparities
1
2023
75
0.200
Why?
Vaccines, Synthetic
1
2022
3
0.200
Why?
Adaptive Immunity
1
2022
18
0.190
Why?
Delivery of Health Care
2
2020
144
0.190
Why?
Vaccination
1
2022
33
0.190
Why?
Antibodies, Viral
1
2022
55
0.190
Why?
Pulmonary Disease, Chronic Obstructive
1
2022
49
0.190
Why?
Treatment Outcome
7
2022
3485
0.180
Why?
Anaphylaxis
1
2021
10
0.180
Why?
Cross-Sectional Studies
6
2021
891
0.180
Why?
Biomedical Technology
1
2021
6
0.180
Why?
Endpoint Determination
1
2021
22
0.180
Why?
Practice Patterns, Physicians'
2
2019
111
0.180
Why?
Mental Health
2
2020
108
0.180
Why?
Feedback
1
2020
33
0.170
Why?
Comparative Effectiveness Research
2
2021
5
0.170
Why?
Remote Sensing Technology
1
2020
3
0.170
Why?
Self-Management
2
2017
12
0.170
Why?
Clinical Coding
1
2020
5
0.170
Why?
Confidentiality
1
2020
5
0.170
Why?
Tiotropium Bromide
1
2020
2
0.170
Why?
Adrenergic beta-2 Receptor Agonists
1
2020
3
0.170
Why?
Desensitization, Immunologic
1
2020
3
0.170
Why?
Depression
3
2020
444
0.170
Why?
Self Report
1
2021
223
0.170
Why?
Clinical Trials as Topic
2
2021
216
0.170
Why?
Lung
1
2021
168
0.170
Why?
Delivery of Health Care, Integrated
1
2020
18
0.170
Why?
Ambulatory Care Facilities
1
2020
39
0.170
Why?
Symptom Flare Up
1
2019
2
0.160
Why?
Health Care Costs
1
2020
75
0.160
Why?
Societies, Medical
1
2020
121
0.160
Why?
Family Relations
1
2019
13
0.160
Why?
Double-Blind Method
3
2023
406
0.160
Why?
Residence Characteristics
2
2019
214
0.160
Why?
Office Visits
1
2019
11
0.160
Why?
Infection Control
1
2020
168
0.160
Why?
Documentation
1
2019
24
0.150
Why?
Pediatrics
1
2019
39
0.150
Why?
Patient Acceptance of Health Care
1
2019
77
0.150
Why?
Outpatients
3
2023
61
0.150
Why?
Occupational Exposure
1
2018
17
0.150
Why?
Patient Participation
1
2018
47
0.150
Why?
Randomized Controlled Trials as Topic
2
2023
292
0.150
Why?
Prevalence
2
2018
443
0.150
Why?
Volunteers
1
2017
4
0.140
Why?
Community Participation
1
2017
17
0.140
Why?
Precision Medicine
1
2017
26
0.140
Why?
Risk Factors
4
2021
2302
0.140
Why?
Education, Distance
1
2017
16
0.140
Why?
Cell Phone
1
2017
7
0.140
Why?
Patient Transfer
1
2016
21
0.130
Why?
Community Mental Health Services
1
2015
15
0.120
Why?
Smartphone
1
2015
15
0.120
Why?
Health Status
3
2021
218
0.120
Why?
Patient Reported Outcome Measures
1
2019
501
0.110
Why?
Retrospective Studies
2
2022
3538
0.110
Why?
Peer Group
1
2013
35
0.110
Why?
Housing
1
2013
18
0.100
Why?
Risk Assessment
3
2021
624
0.100
Why?
Drug Therapy, Combination
3
2020
161
0.100
Why?
Animals
2
2023
3642
0.100
Why?
Quality of Life
3
2023
629
0.100
Why?
Young Adult
4
2022
1994
0.100
Why?
Obesity
2
2019
311
0.100
Why?
Vagus Nerve Stimulation
1
2012
8
0.100
Why?
Chronic Disease
1
2013
415
0.100
Why?
Aged
3
2022
8997
0.100
Why?
Pilot Projects
2
2017
420
0.100
Why?
School Health Services
1
2011
19
0.090
Why?
Chi-Square Distribution
1
2011
139
0.090
Why?
Social Class
1
2011
67
0.090
Why?
Age Factors
1
2013
766
0.090
Why?
Students
1
2011
48
0.090
Why?
Consensus
2
2021
87
0.090
Why?
Mexican Americans
1
2011
26
0.090
Why?
Ambulatory Care
2
2022
69
0.090
Why?
Anti-Allergic Agents
1
2010
2
0.080
Why?
Androstadienes
1
2010
7
0.080
Why?
Quinolines
1
2010
8
0.080
Why?
Rhinitis, Allergic, Seasonal
1
2010
6
0.080
Why?
Acetates
1
2010
16
0.080
Why?
Puerto Rico
3
2014
12
0.080
Why?
Anxiety
2
2021
156
0.080
Why?
Allergens
2
2023
16
0.080
Why?
Respiratory Function Tests
1
2009
32
0.080
Why?
Disease Progression
2
2022
673
0.080
Why?
Logistic Models
2
2019
395
0.070
Why?
Music
1
2008
23
0.070
Why?
Drug Combinations
2
2021
33
0.070
Why?
Emigration and Immigration
1
2006
14
0.070
Why?
Forced Expiratory Volume
2
2019
10
0.070
Why?
Prospective Studies
2
2023
1778
0.050
Why?
Interleukin-8
1
2023
17
0.050
Why?
Interleukin-7
1
2023
12
0.050
Why?
Antibodies
1
2023
46
0.050
Why?
Irritants
1
2023
1
0.050
Why?
Community-Based Participatory Research
2
2014
41
0.050
Why?
Syndrome
1
2023
76
0.050
Why?
Vascular Endothelial Growth Factor A
1
2023
75
0.050
Why?
Post-Exposure Prophylaxis
1
2023
3
0.050
Why?
Dry Powder Inhalers
1
2022
3
0.050
Why?
Metered Dose Inhalers
1
2022
4
0.050
Why?
Patients
1
2022
33
0.050
Why?
Bayes Theorem
1
2022
42
0.050
Why?
Cytokines
1
2023
222
0.050
Why?
Inflammation
1
2023
272
0.050
Why?
RNA, Viral
1
2021
45
0.050
Why?
Stakeholder Participation
1
2021
10
0.050
Why?
Review Literature as Topic
1
2021
10
0.050
Why?
Population Surveillance
1
2022
115
0.050
Why?
Delphi Technique
1
2021
25
0.050
Why?
Substance-Related Disorders
2
2020
94
0.040
Why?
Qualitative Research
1
2021
114
0.040
Why?
London
1
2020
2
0.040
Why?
Terbutaline
1
2020
1
0.040
Why?
Self Administration
1
2020
18
0.040
Why?
United Kingdom
1
2020
47
0.040
Why?
Professionalism
1
2020
4
0.040
Why?
Health Care Rationing
1
2020
5
0.040
Why?
Markov Chains
1
2020
33
0.040
Why?
Immunologic Deficiency Syndromes
1
2020
8
0.040
Why?
Guilt
1
2020
5
0.040
Why?
Efficiency
1
2020
19
0.040
Why?
Suicide
1
2020
12
0.040
Why?
Drug-Related Side Effects and Adverse Reactions
1
2020
18
0.040
Why?
Grief
1
2020
18
0.040
Why?
Cost-Benefit Analysis
1
2020
123
0.040
Why?
Community Health Services
1
2020
34
0.040
Why?
Social Behavior
1
2020
67
0.040
Why?
Dose-Response Relationship, Drug
1
2020
333
0.040
Why?
Mindfulness
1
2020
47
0.040
Why?
Spirituality
1
2020
80
0.040
Why?
Administration, Oral
1
2019
108
0.040
Why?
ROC Curve
1
2019
141
0.040
Why?
Proportional Hazards Models
1
2020
347
0.040
Why?
Communication
1
2020
104
0.040
Why?
Healthcare Disparities
1
2020
88
0.040
Why?
Social Media
1
2020
52
0.040
Why?
Curriculum
1
2020
138
0.040
Why?
Health Care Surveys
1
2019
64
0.040
Why?
Health Promotion
1
2020
143
0.040
Why?
Smoking
1
2019
176
0.040
Why?
Odds Ratio
1
2019
270
0.040
Why?
Educational Status
1
2019
293
0.040
Why?
Comorbidity
1
2019
481
0.030
Why?
Persuasive Communication
1
2017
1
0.030
Why?
Focus Groups
1
2017
87
0.030
Why?
Likelihood Functions
1
2017
27
0.030
Why?
Follow-Up Studies
1
2022
1792
0.030
Why?
Patient Outcome Assessment
1
2016
38
0.030
Why?
Sinusitis
1
2019
162
0.030
Why?
Evidence-Based Practice
1
2016
72
0.030
Why?
Primary Health Care
1
2016
83
0.030
Why?
Interviews as Topic
1
2015
132
0.030
Why?
Schools
1
2014
43
0.030
Why?
Cotinine
1
2013
5
0.030
Why?
Tobacco Smoke Pollution
1
2013
7
0.030
Why?
Enkephalin, Methionine
1
1993
1
0.030
Why?
Saliva
1
2013
52
0.030
Why?
Killer Cells, Natural
1
1993
37
0.030
Why?
Vital Signs
1
2012
3
0.020
Why?
Work of Breathing
1
2012
6
0.020
Why?
Spirometry
1
2012
10
0.020
Why?
Acute Disease
1
2012
176
0.020
Why?
Feasibility Studies
1
2012
220
0.020
Why?
Program Evaluation
1
2011
120
0.020
Why?
Fluticasone-Salmeterol Drug Combination
1
2010
1
0.020
Why?
Cyclopropanes
1
2010
9
0.020
Why?
Sulfides
1
2010
10
0.020
Why?
Administration, Intranasal
1
2010
26
0.020
Why?
Stress, Psychological
1
2012
235
0.020
Why?
Illinois
1
2009
250
0.020
Why?
Body Mass Index
1
2009
458
0.020
Why?
Sensitivity and Specificity
1
2005
482
0.010
Why?
Vietnam
1
1993
7
0.010
Why?
In Vitro Techniques
1
1993
175
0.010
Why?
Analysis of Variance
1
1993
260
0.010
Why?
Alcoholism
1
1993
67
0.010
Why?
Veterans
1
1993
96
0.010
Why?
Mosnaim's Networks
Click the
Explore
buttons for more information and interactive visualizations!
Concepts (261)
Explore
_
Co-Authors (6)
Explore
_
Similar People (60)
Explore
_
Same Department Expand Description
Explore
_